Limited-Dose Daclizumab Versus Basiliximab: A Comparison of Cost and Efficacy in Preventing Acute Rejection - Concepedia

Concepedia

Publication | Closed Access

Limited-Dose Daclizumab Versus Basiliximab: A Comparison of Cost and Efficacy in Preventing Acute Rejection

24

Citations

7

References

2005

Year

Kelly Pham, K Kraft, J. Thielke, José Oberholzer, Howard Sankary, Giuliano Testa, Enrico Benedetti

Transplantation Proceedings

TransplantationMedicineMetronomic TherapyTreatment OptionPharmacotherapyPharmacologyPreventing Acute Rejection

References

	Year	Citations

Page 1